Cardiovascular Outcomes Registry in Cardiogenic SHOCK (COR-SHOCK)

Recruiting Observational Study
Cardiogenic Shock Acute Cardiogenic Shock Cardiogenic Shock Post Myocardial Infarction
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
800 (estimated)
Sponsor
Hospital de Santa Cruz, Portugal · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to evaluate the clinical outcomes and management approaches of cardiogenic shock throughout the years in adult patients admitted to a Cardiology Department. The main questions it aims to answer are: * How have management strategies and clinical outcomes for cardiogenic shock evolved over time? * How do clinical, laboratory, and advanced hemodynamic monitori…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: -Cardiogenic shock according to the following criteria: Cardiac disorder resulting in hypotension, defined as at least one of the following: * Systolic blood pressure (SBP) \<90 mmHg for ≥30 minutes, or * Requirement for vasopressors, inotropes, or mechanical circulatory suppo…
Contacts

João Presume, MD

+351 21 043 1000

jppereira@ulslo.min-saude.pt

CONTACT